Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F PRESCOTT

Showing results (351-360 of 383) with videos related to

Pageof 39
Sort By:
Cellular Microbiology|October 20, 2012
Diversion of phagosome trafficking by pathogenic Rhodococcus equi depends on mycolic acid chain lengthTobias Sydor, Kristine von Bargen, Fong-Fu Hsu, et al.
JACC. Heart Failure|December 14, 2020
Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without DiabetesMuhammad Shahzeb Khan, G Michael Felker, Ileana L Piña, et al.
JAMA|September 3, 2019
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection FractionJames L Januzzi, Margaret F Prescott, Javed Butler, et al.
Circulation. Heart Failure|May 17, 2021
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alan S Maisel, et al.
JACC. Heart Failure|November 15, 2020
Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection FractionIleana L Piña, Alexander Camacho, Nasrien E Ibrahim, et al.
Canadian Journal of Comparative Medicine : Revue Canadienne De Medecine Comparee|January 1, 1980
Factors associated with mortality in feedlot cattle: the Bruce County Beef Cattle ProjectS W Martin, A H Meek, D G Davis, et al.
Cancer Research|October 7, 2020
Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS TrialConnie C Wong, Jason Baum, Angela Silvestro, et al.
JACC. Heart Failure|November 15, 2020
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alexander Camacho, et al.
JACC. Heart Failure|April 4, 2016
Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF TrialPeter S Pang, John R Teerlink, Adriaan A Voors, et al.
Circulation. Heart Failure|March 21, 2023
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF TrialJawad H Butt, Wasyla Ibrahim, Pooja Dewan, et al.
Pageof 39

Showing results (351-360 of 383) with videos related to

Sort By:
Pageof 39
Cellular Microbiology|October 20, 2012
Diversion of phagosome trafficking by pathogenic Rhodococcus equi depends on mycolic acid chain lengthTobias Sydor, Kristine von Bargen, Fong-Fu Hsu, et al.
JACC. Heart Failure|December 14, 2020
Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without DiabetesMuhammad Shahzeb Khan, G Michael Felker, Ileana L Piña, et al.
JAMA|September 3, 2019
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection FractionJames L Januzzi, Margaret F Prescott, Javed Butler, et al.
Circulation. Heart Failure|May 17, 2021
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alan S Maisel, et al.
JACC. Heart Failure|November 15, 2020
Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection FractionIleana L Piña, Alexander Camacho, Nasrien E Ibrahim, et al.
Canadian Journal of Comparative Medicine : Revue Canadienne De Medecine Comparee|January 1, 1980
Factors associated with mortality in feedlot cattle: the Bruce County Beef Cattle ProjectS W Martin, A H Meek, D G Davis, et al.
Cancer Research|October 7, 2020
Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS TrialConnie C Wong, Jason Baum, Angela Silvestro, et al.
JACC. Heart Failure|November 15, 2020
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alexander Camacho, et al.
JACC. Heart Failure|April 4, 2016
Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF TrialPeter S Pang, John R Teerlink, Adriaan A Voors, et al.
Circulation. Heart Failure|March 21, 2023
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF TrialJawad H Butt, Wasyla Ibrahim, Pooja Dewan, et al.
Pageof 39